- World rank, 2022–2025
- #13,375 of 28,054 · #23,237 all time
- Rank in China
- #2,253 of 3,058
- Research works
- 666 ▲ 5% vs 2013–17
- Citations
- 5.8k 8.8 per fractional work
- Top-10% rate
- 17.1% record average 16.5%
- Open access
- 39% world 28%
What is Tianjin Third Central Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,871 of 10,443 | 14.8% | 103 | #12163 | |
| Health SciencesDomain | #7,646 of 11,982 | 14.8% | 106 | #14957 |
Each strip is that field’s whole ranked pool, with the notch where Tianjin Third Central Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.3×. Every wedge is a field page.
- Immunology and Microbiology 3.3×
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 3.1×
- Pharmacology, Toxicology and Pharmaceutics 1.8×
- Neuroscience 1.7×
- Nursing 1.5×
- Veterinary 1.3×
- Chemistry 0.5×
- Materials Science 0.4×
- Environmental Science 0.3×
- Engineering 0.3×
- Health Professions 0.3×
- Psychology 0.1×
- Energy 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.0×
- Physics and Astronomy 0.0×
- Social Sciences 0.0×
Which keywords describe research at Tianjin Third Central Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Hepatocellular Carcinoma, Inflammation, Treatment, Management, Diagnosis, Metabolic Syndrome and Tumor Microenvironment.
- GPX4
- Cancer Biomarkers
- Lipid Peroxidation
- Liver Cirrhosis
- Regulation
- Antiviral Therapy
- Liver Disease
- Metastasis
- Cell Death
- Cardiovascular Disease
- NASH
- Liver Cancer
- Radiofrequency Ablation
- Hepatic Steatosis
- Insulin Resistance
- Tumor Microenvironment
- Oxidative Stress
- Diagnosis
- Hepatocellular Carcinoma
- Inflammation
- Cancer
- Epidemiology
- Treatment
- Management
- Metabolic Syndrome
- Clinical Practice Guidelines
- Immune Response
- Biomarkers
- Survival
- NAFLD
- Sorafenib
- Gene Expression
- Prognostic Factors
- Immunity
- Coagulopathy
- Biogenesis
- Hepatic Encephalopathy
- Critical Care
- Thrombosis
- Ferroptosis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer17▲ 7.8×34 topics
- Inflammation16▲ 4.8×56 topics
- Epidemiology15▲ 2.4×55 topics
- Hepatocellular Carcinoma15▲ 44×3 topics
- Treatment12▲ 6.3×22 topics
- Diagnosis10▲ 6.8×19 topics
- Management10▲ 8.0×10 topics
- Oxidative Stress10▲ 3.8×32 topics
- Metabolic Syndrome9▲ 7.2×13 topics
- Tumor Microenvironment9▲ 12×8 topics
- Clinical Practice Guidelines9▲ 10.0×10 topics
- Insulin Resistance8▲ 12×7 topics
- Immune Response7▲ 8.1×15 topics
- Hepatic Steatosis7▲ 28×2 topics
- Biomarkers7▲ 6.1×13 topics
- Radiofrequency Ablation7▲ 39×2 topics
- Survival7▲ 31×3 topics
- Liver Cancer6▲ 73×1 topic
- NAFLD6▲ 34×1 topic
- NASH6▲ 34×1 topic
- Sorafenib6▲ 73×1 topic
- Cardiovascular Disease6▲ 3.6×26 topics
- Gene Expression6▲ 6.1×7 topics
- Cell Death5▲ 13×6 topics
- Prognostic Factors5▲ 7.1×10 topics
- Metastasis5▲ 8.4×9 topics
- Immunity4▲ 6.9×6 topics
- Liver Disease4▲ 29×3 topics
- Coagulopathy4▲ 34×2 topics
- Antiviral Therapy4▲ 26×3 topics
- Biogenesis4▲ 14×3 topics
- Regulation4▲ 4.6×7 topics
- Hepatic Encephalopathy4▲ 42×1 topic
- Liver Cirrhosis4▲ 42×1 topic
- Critical Care4▲ 9.5×7 topics
- Lipid Peroxidation3▲ 20×3 topics
- Thrombosis3▲ 7.3×6 topics
- Cancer Biomarkers3▲ 24×3 topics
- Ferroptosis3▲ 25×1 topic
- GPX43▲ 25×1 topic
Which research topics does Tianjin Third Central Hospital publish most on?
By volume in 2022–2025: Liver Disease Diagnosis and Treatment, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation and Ferroptosis and cancer prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Liver Disease Diagnosis and Treatment Epidemiology 6 works
- 2 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 6 works
- 3 Liver Disease and Transplantation Hepatology 4 works
- 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 3 works
- 5 Cancer-related molecular mechanisms research Cancer Research 2 works
- 6 Hepatitis C virus research Hepatology 2 works
- 7 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 2 works
- 8 Hepatitis B Virus Studies Epidemiology 2 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 10 Circular RNAs in diseases Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tianjin Third Central Hospital's research output changed?
Output in 2018–2022 was 5% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tianjin
- Tianjin University
- Nankai University
- Hebei University of Technology
- Tianjin University of Technology
- Tiangong University
- Tianjin Medical University
- Tianjin University of Science and Technology
- Civil Aviation University of China
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.